Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A retinopathy, typically described as achromatopsia, caused by biallelic variants in the CNGA3 gene.
Biomarker and diagnostic research for CNGA3-related retinopathy has been reported in the published literature.
1 clinical trial registered. Interventions under study include biologic therapy. Pipeline includes 1 PHASE1. Research is primarily industry-sponsored.
102 publications have been identified in PubMed for CNGA3-related retinopathy. Research spans Basic Science / Preclinical (39%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (12%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 40 | 39% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:07 PM UTC
Common questions about CNGA3-related retinopathy
Research summaries |
23 |
23% |
Disease patterns and progression | 12 | 12% |
New treatment approaches | 11 | 11% |
Patient case studies | 7 | 7% |
Testing and diagnosis research | 5 | 5% |
Clinical study results | 4 | 4% |
Hang C (2026). [PMID: 41448484](https://pubmed.ncbi.nlm.nih.gov/41448484/). *American journal of ophthalmology*. [Epidemiology / Natural History]
Wang X (2026). [PMID: 41349895](https://pubmed.ncbi.nlm.nih.gov/41349895/). *Ageing research reviews*. [Basic Science / Preclinical]
Mukundan A (2026). [PMID: 41316839](https://pubmed.ncbi.nlm.nih.gov/41316839/). *Ocular immunology and inflammation*. [Case Report / Case Series]
Niaudet C (2026). [PMID: 41271176](https://pubmed.ncbi.nlm.nih.gov/41271176/). *Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology*. [Basic Science / Preclinical]
Pavlou M (2026). [PMID: 42020901](https://pubmed.ncbi.nlm.nih.gov/42020901/). *Methods Mol Biol*. [Gene Therapy / Novel Therapeutics]
Wang X (2026). [PMID: 41662529](https://pubmed.ncbi.nlm.nih.gov/41662529/). *Proceedings of the National Academy of Sciences of the United States of America*. [Case Report / Case Series]
Sreenivas Bk A (2025). [PMID: 40499707](https://pubmed.ncbi.nlm.nih.gov/40499707/). *Experimental eye research*. [Review / Meta-Analysis]
Purdy R (2025). [PMID: 40090458](https://pubmed.ncbi.nlm.nih.gov/40090458/). *Progress in retinal and eye research*. [Gene Therapy / Novel Therapeutics]
Liu S (2025). [PMID: 40249604](https://pubmed.ncbi.nlm.nih.gov/40249604/). *Investigative ophthalmology & visual science*. [Case Report / Case Series]
Hartman GD (2025). [PMID: 40305885](https://pubmed.ncbi.nlm.nih.gov/40305885/). *Redox biology*. [Basic Science / Preclinical]